Kristin Baldwin

Kristin Baldwin is a Professor of Genetics and Development at Columbia University and member of the Columbia Stem Cell Initiative. She is a pioneer in reprogramming and stem cell biology. Her research applies reprogramming to assess the impact of aging on diverse cell types and to engineer new cellular models for neurologic, and cardiovascular disease. Dr. Baldwin's earlier notable work included being the first to clone a mouse from a neuron and then sequence its genome and producing an entire mouse from a skin cell with iPSCs. Her work has been published in premiere journals (i.e Nature, Cell) and has garnered awards (i.e. Pew Scholar, Kavli Fellow and NIH Pioneer Award). Dr. Baldwin holds a Ph.D. in Immunology from Stanford and performed postdoctoral work in Neurobiology at Columbia University with Dr. Richard Axel. She holds several patents and is a co-founder and board observer of Certego Therapeutics.